Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biofac is a Danish pharmaceutical and biochemical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) derived from natural sources. Founded in 1947, the company produces a wide range of products including heparin, chondroitin sulfate, and various enzymes and gastric mucins for the pharmaceutical, veterinary, and nutraceutical industries. Biofac operates multiple GMP-certified manufacturing facilities in Denmark, providing high-quality biological components to global markets. The company is recognized for its expertise in extraction and purification processes, serving as a key supplier for treatments in hematology, rheumatology, and gastroenterology. Their business model focuses on high-purity natural extracts and contract manufacturing services for the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biofac A.